Humana Inc. (HUM)
The price, the headline numbers and the latest news, in one place.
Humana Inc. (HUM) Stock Price, Analysis & Data
| Bid | 386 |
| Market Cap | 48.2B |
| Revenue (ttm) | 146B |
| Net Income (ttm) | 1.28B |
| 0.74 | |
| 10.57 | |
| 37.99 | |
| 24.24 | |
| P/B (ttm) | 2.51 |
| P/S (ttm) | 0.33 |
| Earnings Date | Nov 6, 2026 |
| Ask | 410.6 |
| Volume | 772,778 |
| Avg. Volume (20D) | 1,360,798 |
| Open | 404.34 |
| Previous Close | 406.52 |
| Day's Range | 398.59 - 409.06 |
| 52-Week Range | 163.11 - 428.88 |
| Analyst | Buy |
| Price Target | 415 (3.35%) |
| Dividends | $3.54 (0.87%) |
| Ex-Dividend Date | Oct 30, 2026 |
About HUM
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicar...
Financial Performance
In 2025, Humana's revenue was 129.66B, an increase of 10.11% compared to the previous year's 117.76B. Earnings were 1.19B, a decrease of -1.57%.
Financial StatementsAnalyst Forecast
According to 23 analyst ratings, the average rating for HUM stock is "Buy". The 12-month stock price forecast is 415, which is upside of 3.35% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $40.87B misses estimates by $0, with 26.18% YoY growth.
- EPS of 7.61 exceeds estimates by 0.61, with 21.37% YoY growth.
Analysts project revenue of ... Upgrade
